The Beauty Health Company (NASDAQ:SKIN) Receives $6.29 Consensus PT from Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have earned a consensus rating of “Reduce” from the twelve ratings firms that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and two have given a buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $6.14.

Several equities analysts recently weighed in on the company. DA Davidson reissued a “buy” rating and set a $5.00 price objective on shares of Beauty Health in a research report on Monday, May 13th. Canaccord Genuity Group upped their target price on shares of Beauty Health from $3.00 to $4.00 and gave the company a “hold” rating in a research note on Thursday, March 14th. TD Cowen decreased their price target on shares of Beauty Health from $4.00 to $3.00 and set a “hold” rating on the stock in a research report on Monday, May 13th. Finally, Piper Sandler cut their price objective on shares of Beauty Health from $2.50 to $1.50 and set an “underweight” rating for the company in a research report on Thursday.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SKIN. Raymond James & Associates acquired a new position in shares of Beauty Health in the 4th quarter worth approximately $31,000. Raymond James Financial Services Advisors Inc. acquired a new position in Beauty Health during the fourth quarter worth $31,000. HighMark Wealth Management LLC bought a new position in shares of Beauty Health during the first quarter valued at $31,000. SageView Advisory Group LLC acquired a new stake in shares of Beauty Health in the 1st quarter valued at $60,000. Finally, Aigen Investment Management LP increased its position in shares of Beauty Health by 88.7% during the 4th quarter. Aigen Investment Management LP now owns 31,865 shares of the company’s stock worth $99,000 after purchasing an additional 14,974 shares in the last quarter. Institutional investors own 93.26% of the company’s stock.

Beauty Health Stock Up 4.5 %

SKIN opened at $1.84 on Friday. Beauty Health has a twelve month low of $1.35 and a twelve month high of $8.96. The company has a debt-to-equity ratio of 10.51, a quick ratio of 5.55 and a current ratio of 6.57. The business has a 50 day moving average price of $2.28 and a 200 day moving average price of $2.96. The firm has a market cap of $227.48 million, a P/E ratio of -2.63 and a beta of 0.96.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings data on Thursday, May 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.04. The business had revenue of $81.40 million during the quarter, compared to the consensus estimate of $80.56 million. Beauty Health had a negative net margin of 20.48% and a negative return on equity of 0.02%. Beauty Health’s quarterly revenue was down 5.7% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.17) EPS. Research analysts forecast that Beauty Health will post -0.07 EPS for the current year.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.